Literature DB >> 10811041

Urinary tract infections, antibiotic resistance and sales of antimicrobial drugs--an observational study of uncomplicated urinary tract infections in Icelandic women.

M Olafsson1, K G Kristinsson, J A Sigurdsson.   

Abstract

OBJECTIVES: To analyse the antimicrobial susceptibility pattern of bacteria causing symptomatic but otherwise uncomplicated lower urinary tract infections (UTI) in primary health care and the sales of antimicrobial drugs.
SETTING: Primary health care in Akureyri District, Northern Iceland, with about 17400 inhabitants. PATIENTS: A total of 516 episodes of symptomatic but otherwise uncomplicated lower UTI in women 10 to 69 years of age. MAIN OUTCOME MEASURES: Number of verified UTI, bacterial species, antimicrobial susceptibility pattern, and total sales of antimicrobial drugs.
RESULTS: Escherichia coli was by far the most common cause of UTI (83%), followed by Staphylococcus saprophyticus (7%). Infections caused by E. coli resistant to ampicillin accounted for 36% of cases, with the corresponding figures for sulfafurazol being 37%, cephalothin 45%, trimethoprim 13% and mecillinam 14%. Only 1% of the strains were resistant to nitrofurantoin. The total use of antimicrobial drugs was 17.4 DDD/1000 inhabitants/day.
CONCLUSIONS: The resistance of bacteria causing uncomplicated UTI to common antimicrobials is high and must be taken into account when selecting treatment strategies. High consumption of antibiotics in the community indicates possible association.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811041     DOI: 10.1080/02813430050202532

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  5 in total

1.  Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project.

Authors:  Sven A Ferry; Stig E Holm; Hans Stenlund; Rolf Lundholm; Tor J Monsen
Journal:  Scand J Prim Health Care       Date:  2007-03       Impact factor: 2.581

2.  Lipopolysaccharide Domains Modulate Urovirulence.

Authors:  Lizath M Aguiniga; Ryan E Yaggie; Anthony J Schaeffer; David J Klumpp
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

3.  Catheter-associated and nosocomial urinary tract infections: antibiotic resistance and influence on commonly used antimicrobial therapy.

Authors:  Potic B Milan; Ignjatovic M Ivan
Journal:  Int Urol Nephrol       Date:  2008-09-12       Impact factor: 2.370

4.  Community-acquired Lower Urinary Tract Infections: Etiology, Antimicrobial Resistance, and Treatment Results in Female Patients.

Authors:  Ilknur Erdem; Ridvan Kara Ali; Enes Ardic; Senay Elbasan Omar; Reyhan Mutlu; Aynur Eren Topkaya
Journal:  J Glob Infect Dis       Date:  2018 Jul-Sep

5.  Presumed Urinary Tract Infection in Patients Admitted with COVID-19: Are We Treating Too Much?

Authors:  Johan Van Laethem; Stephanie C M Wuyts; Jan Pierreux; Lucie Seyler; Gil Verschelden; Thibault Depondt; Annelies Meuwissen; Patrick Lacor; Denis Piérard; Sabine D Allard
Journal:  Antibiotics (Basel)       Date:  2021-12-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.